Payers face challenges incorporating drug spending into value-based payment models, making it difficult to reduce overall health care costs, according to panelists who participated in a session at the recent Value-Based Payment Summit.
Key Takeaways
-
Various government and private payer initiatives are good steps forward on accountable care, but will not be as effective as possible because of a lack of coordination.
The speakers were encouraged by the increased attention being paid to expensive medications and difficulties in ensuring people take their...
